Kimberly Manhard is SVP & Regulatory & Dev Ops at Ardea Biosciences, Inc./DE (RDEA). They have made 14 open-market trades across 3 companies since 2009, most recently 2026-09-15.
CIK 0001202094
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $140K since 2024, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| INBX | 7,500 | $668K |
| HRTX | 25,183 | $9K |
| RDEA | 17,481 | — |
| Total | $677K |
Shares reported on the most recent Form 4, priced at the 2026-09-15 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| INBX | SELL | 2026-09-11 | 2026-09-15 | $109.03 | $164K | -5.1% | -13.0% | — |
| INBX | SELL | 2026-09-08 | 2026-09-10 | $115.47 | $115K | -3.6% | -21.1% | — |
| INBX | BUY | 2024-08-28 | 2024-08-30 | $13.98 | $140K | +2.9% | +6.9% | +4.2% |
| HRTX | SELL · 10b5-1 | 2022-05-03 | 2022-05-04 | $4.76 | $7K | -25.3% | -36.7% | -40.9% |
| HRTX | SELL · 10b5-1 | 2021-05-03 | 2021-05-04 | $17.66 | $27K | -19.5% | -20.9% | -28.1% |
| HRTX | SELL | 2020-12-22 | 2020-12-23 | $20.00 | $200K | -5.4% | -14.6% | -28.1% |
| HRTX | SELL · 10b5-1 | 2020-05-01 | 2020-05-01 | $13.97 | $16K | +6.1% | +37.1% | +25.3% |
| HRTX | SELL | 2019-11-29 | 2019-12-03 | $26.00 | $624K | -4.8% | -13.2% | -31.5% |
| HRTX | SELL · 10b5-1 | 2019-05-01 | 2019-05-02 | $18.86 | $21K | +1.2% | -1.2% | -2.6% |
| HRTX | SELL · 10b5-1 | 2018-11-02 | 2018-11-02 | $30.62 | $15K | -8.1% | -2.2% | -10.2% |
| HRTX | SELL | 2018-10-01 | 2018-10-02 | $32.07 | $192K | -5.3% | -0.0% | -16.4% |
| HRTX | SELL | 2018-07-02 | 2018-07-03 | $37.53 | $225K | -1.9% | -7.1% | -21.1% |
| HRTX | SELL | 2018-03-19 | 2018-03-19 | $30.00 | $540K | +0.0% | +11.8% | +7.4% |
| HRTX | SELL | 2018-01-10 | 2018-01-12 | $20.00 | $152K | +8.6% | -2.9% | +37.5% |
| HRTX | SELL | 2017-04-24 | 2017-04-24 | $15.33 | $330K | -0.6% | -3.2% | +9.7% |
| HRTX | SELL | 2017-04-24 | 2017-04-24 | $15.33 | $661K | -0.6% | -3.2% | +9.7% |
| HRTX | SELL | 2015-06-01 | 2015-06-03 | $23.09 | $305K | -13.8% | -3.9% | -3.9% |
| RDEA | SELL | 2012-06-19 | 2012-06-20 | $31.96 | $410K | N/A | N/A | N/A |
| RDEA | SELL · 10b5-1 | 2012-05-29 | 2012-05-29 | $31.89 | $159K | N/A | N/A | N/A |
| RDEA | SELL · 10b5-1 | 2012-04-30 | 2012-04-30 | $31.82 | $159K | N/A | N/A | N/A |
| RDEA | SELL · 10b5-1 | 2012-03-28 | 2012-03-29 | $22.65 | $113K | N/A | N/A | N/A |
| RDEA | SELL · 10b5-1 | 2012-02-28 | 2012-02-29 | $20.99 | $105K | N/A | N/A | N/A |
| RDEA | SELL · 10b5-1 | 2012-01-30 | 2012-01-31 | $18.01 | $90K | N/A | N/A | N/A |
| RDEA | SELL · 10b5-1 | 2011-12-28 | 2011-12-29 | $16.97 | $85K | N/A | N/A | N/A |
| RDEA | SELL · 10b5-1 | 2011-11-28 | 2011-11-29 | $17.67 | $88K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.